BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/25/2024 9:10:45 AM | Browse: 196 | Download: 703
 |
Received |
|
2024-06-18 13:17 |
|
Peer-Review Started |
|
2024-06-18 13:17 |
|
First Decision by Editorial Office Director |
|
2024-10-11 04:21 |
|
Return for Revision |
|
2024-10-11 04:21 |
|
Revised |
|
2024-10-12 07:51 |
|
Publication Fee Transferred |
|
2024-10-21 06:11 |
|
Second Decision by Editor |
|
2024-11-07 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-11-07 10:01 |
|
Articles in Press |
|
2024-11-07 10:01 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-11-18 01:21 |
|
Publish the Manuscript Online |
|
2024-11-25 09:10 |
| ISSN |
2307-8960 (online) |
| Open Access |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Anlotinib-induced sick sinus syndrome: Two case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Cheng-Feng Fu, Li-Fen Yang, Lei Tian, Song Deng, Qi Zhang and Biao Yao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Qi Zhang, Associate Chief Physician, PhD, Department of Oncology, Guizhou Provincial People’s Hospital, No. 83 Zhongshan East Road, Nanming District, Guiyang 550000, Guizhou Province, China. kekexinqing@163.com |
| Key Words |
Lung cancer; Anlotinib; Sick sinus syndrome; Cardiac pacemaker; Adverse drug reaction; Case report |
| Core Tip |
This case report presents the first known instances of sick sinus syndrome associated with the use of anlotinib in patients with non-small cell lung cancer, emphasizing the importance of cardiac monitoring during treatment. The report compares two different management approaches for anlotinib-induced sick sinus syndrome, one with a dual-chamber permanent pacemaker and the other with medication discontinuation, providing valuable insights for clinical practice. |
| Publish Date |
2024-11-25 09:10 |
| Citation |
Fu CF, Yang LF, Tian L, Deng S, Zhang Q, Yao B. Anlotinib-induced sick sinus syndrome: Two case reports. World J Clin Cases 2025; 13(6): 98084 |
| URL |
https://www.wjgnet.com/2307-8960/full/v13/i6/98084.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v13.i6.98084 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
